Glow
- Home
- Glow
Glow
GLOW is a research blend containing GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg, for a combined strength of 70 mg. It is formulated for laboratory studies examining the cellular pathways involved in tissue remodeling, extracellular-matrix activity, angiogenesis, oxidative stress, and inflammatory signaling.
Research components
- GHK-Cu: A copper-binding tripeptide investigated for collagen production, fibroblast activity, gene expression, antioxidant responses, and skin-remodeling pathways. Published research
- BPC-157: An experimental 15-amino-acid peptide studied primarily in preclinical models involving angiogenesis, collagen organization, gastrointestinal integrity, and connective-tissue responses.
- TB-500: A synthetic research peptide associated with thymosin-beta-4 activity and studied for actin regulation, cell migration, blood-vessel formation, and tissue-repair mechanisms. Thymosin-beta-4 research
Research-grade GLOW is commonly used to investigate:
- Collagen synthesis and extracellular-matrix remodeling
- Fibroblast, keratinocyte, and endothelial-cell activity
- Angiogenesis and cell-migration pathways
- Oxidative-stress and inflammatory signaling
- Skin, connective-tissue, and wound-model responses
- Interactions among multiple tissue-remodeling peptides
GLOW is a commercial research blend—not a single naturally occurring peptide—and the combination itself has not been established as safe or effective in humans. Most supporting evidence for its components is preclinical and should not be presented as proven cosmetic, healing, or anti-aging benefits.
For laboratory research and analytical testing only. Not for human or veterinary use. This product is not intended to diagnose, treat, cure, or prevent any disease.
